The US Food and Drug Administration (FDA) accepted and granted Priority Review designation for Bayer’s (BAYN: DE) supplemental new drug application (sNDA) for a new indication for Kerendia (finerenone ...
This is the third part of a series on the illegalities of a new community forest in Grand Bassa County. VAMBO, Grand Bassa County – Early last month, The DayLight started a series on a newly ...
One practice now under greater scrutiny is health care insurers’ use of artificial intelligence (AI) algorithms to deny ...
Proposals to eliminate the self-affirmed GRAS pathway have sent shockwaves through the food industry. But what do they mean ...
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...
Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...
Pet owners want the best when it comes to feeding their four-legged friends. And with so many dog food choices, from fresh to ...
The Health and Human Services Secretary directed the FDA to consider eliminating a pathway that allowed companies to ...
Whether or not telehealth companies are under FDA jurisdiction when marketing and promoting prescription drugs has been under ...
The use of CLPH-511 in acute hemorrhage is currently being investigated in a Phase 2/3 adaptive design study, titled ...
FILSPARI REMS: Due to the risk of hepatotoxicity and embryo-fetal toxicity, FILSPARI is available only through a restricted program called the FILSPARI REMS. Prescribers, patients, and pharmacies must ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback